Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Denis Chem LabBOM:537536 +1.58%78 Days Payable is 77.26 as of Mar. 2026, which is 11% below its 10-year median of 86.97. GuruFocus rates BOM:537536 with a GF Score™ of 78/100 and a GF Value™ of ₹118.54 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 927 Drug Manufacturers companies, Denis Chem Lab ranks worse than 56.42% on this metric.
The historical rank and industry rank for Denis Chem Lab's Days Payable or its related term are showing as below:
BOM:537536'
s Days Payable Range Over the Past 10 Years
Min: 80.03 Med: 86.97 Max: 146.64
Current: 80.21
During the past 13 years, Denis Chem Lab's highest Days Payable was 146.64. The lowest was 80.03. And the median was 86.97.
BOM:537536's Days Payable is ranked worse than 56.42% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs BOM:537536: 80.21
Denis Chem Lab's Days Payable
declined
from Mar. 2025 (85.71) to Mar. 2026 (77.26).
It may suggest that Denis Chem Labaccelerated paying its suppliers.
Denis Chem Lab Days Payable Related Terms
Denis Chem Lab Days Payable Historical Data
* Premium members only.
The historical data trend for Denis Chem Lab's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Denis Chem Lab's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Denis Chem Lab Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Denis Chem Lab's Days Payable distribution charts can be found below:
* The bar in red indicates where Denis Chem Lab's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Denis Chem Lab's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Denis Chem Lab (BOM:537536) has a Days Payable of 77.26 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Denis Chem Lab and its competitors. This is 11% below median its historical median of 86.97. Over the past decade, Denis Chem Lab's Days Payable has ranged from 80.03 to 146.64. According to the industry distribution chart, Denis Chem Lab ranks #523 out of 927 companies in the Drug Manufacturers industry, placing it in the top 56.4%.
Is Denis Chem Lab's Days Payable too high?
Denis Chem Lab's current Days Payable of 77.26 is 11% below median its 10-year median of 86.97. Over the past 10 years, this metric has ranged from a low of 80.03 to a high of 146.64. The Drug Manufacturers industry median Days Payable is 90.38. Denis Chem Lab's value of 77.26 is 14.5% below this industry median. Based on the distribution chart, Denis Chem Lab ranks #523 out of 927 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Denis Chem Lab has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Denis Chem Lab's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Denis Chem Lab ranks #523 out of 927 companies for Days Payable. This places Denis Chem Lab in the lower half of its industry. The industry median Days Payable is 90.38. Denis Chem Lab's value of 77.26 is 14.5% below this benchmark. Historically, Denis Chem Lab's own Days Payable has ranged from 80.03 to 146.64 over the past decade. While the company's 10-year median is 86.97 vs. the industry median of 90.38, Denis Chem Lab has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Denis Chem Lab's current Days Payable of 77.26 is 14.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Denis Chem Lab and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Denis Chem Lab's current Days Payable is 77.26, which is 11% below median its own 10-year median of 86.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Denis Chem Lab stock overvalued right now?
Based on GuruFocus' analysis, Denis Chem Lab (BOM:537536) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹118.54, compared to a current price of ₹71.81 — trading 39.4% below its estimated fair value. The current Days Payable is 77.26, which is 11% below median its 10-year median of 86.97 and 14.5% below the Drug Manufacturers industry median of 90.38. Denis Chem Lab's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Denis Chem Lab (BOM:537536), the current Days Payable is 77.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Denis Chem Lab (BOM:537536) Overvalued in 2026?
Based on GuruFocus' analysis, Denis Chem Lab stock appears to be undervalued.
The current stock price of ₹71.81 is trading 39.4% below its estimated GF Value™ of ₹118.54.
GuruFocus considers Denis Chem Lab to be Significantly Undervalued.
Key valuation signals for BOM:537536:
Days Payable: 77.26 (11% below median its 10-year median of 86.97)
GF Value™: ₹118.54 vs. price of ₹71.81 (39.4% below fair value)
Industry Position: 14.5% below the Drug Manufacturers median (#523 of 927)
No single metric tells the full story. See the BOM:537536 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Denis Chem Lab Ltd is a pharmaceutical company involved in the manufacturing of pharmaceutical products. The company offers sterile intravenous injectables for human and veterinary use for different therapeutic areas. Its product portfolio includes antibiotic injections, diuretic injections, parenteral amino acid injections, plasma volume expanders, anti-pyretic Inj. irrigation solutions and dialysis solutions. The company has only one reportable segment which is Manufacturing, and Sales of Transfusion Solution in Bottles It generates its revenues through the sale of transfusion solution in bottles.
78GF Score
Get the complete analysis for BOM:537536
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:537536 has been successfully added to your 
